Please login to the form below

Not currently logged in
Email:
Password:

Constellation Pharmaceuticals

This page shows the latest Constellation Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Merck stumps up $375m for cancer firm OncoEthix

Merck stumps up $375m for cancer firm OncoEthix

tumours. The acquisition is Merck's second this month after it agreed an $8.4bn takeover deal with anti-infectives specialist Cubist Pharmaceuticals. ... Other companies working in the BET inhibitor area include GlaxoSmithKline (GSK) with I-BET762, also

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in August 2015 Pharma deals in August 2015

    Immuno-oncology combinations in lung cancer. Not disclosed. Peregrine Pharmaceuticals. Combination clinical trials. ... This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Constellation Pharmaceuticals appoints Emma Reeve as CFO Constellation Pharmaceuticals appoints Emma Reeve as CFO

    US-based Constellation Pharmaceuticals has appointed Emma Reeve as its chief financial officer to bolster the biopharma’s finance efforts. ... Additionally, Brad Prosek (pictured left) joins Constellation Pharmaceuticals as senior vice president,

  • Constellation Pharmaceuticals strengthens management team Constellation Pharmaceuticals strengthens management team

    Appointments include Adrian Senderowicz as chief medical officer. Cambridge, UK-based Constellation Pharmaceuticals has appointed Adrian Senderowicz as its senior vice president and chief medical officer. ... He said: “Constellation Pharmaceuticals is

  • Constellation Pharmaceuticals appoints Jigar Raythatha as CEO Constellation Pharmaceuticals appoints Jigar Raythatha as CEO

    US firm has also bolstered its scientific advisory board. Constellation Pharmaceuticals has appointed Jigar Raythatha as its new chief executive officer (CEO) and president in a role that marks his return ... Mark Goldsmith, executive chairman of

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics